CLOPID 75 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

CLOPIDOGREL 75 MG

Disponible desde:

TARO INTERNATIONAL LTD

Código ATC:

B01AC04

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

PHARMATHEN S.A., GREECE

Grupo terapéutico:

CLOPIDOGREL

indicaciones terapéuticas:

Clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy

Fecha de autorización:

2010-09-01